Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
Sophie Brinster,
Gilles Lamberet,
Bart Staels,
Patrick Trieu-Cuot,
Alexandra Gruss () and
Claire Poyart ()
Additional contact information
Sophie Brinster: Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
Gilles Lamberet: INRA, UR888, Unité Bactéries Lactiques et Pathogènes Opportunistes, F-78350, Jouy en Josas, France
Bart Staels: Institut Pasteur de Lille, INSERM UMR545, Université Lille 2
Patrick Trieu-Cuot: Institut Pasteur, Unité de Biologie des Bactéries Pathogènes à Gram Positif, URA CNRS 2172, Paris, France
Alexandra Gruss: INRA, UR888, Unité Bactéries Lactiques et Pathogènes Opportunistes, F-78350, Jouy en Josas, France
Claire Poyart: Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
Nature, 2009, vol. 458, issue 7234, 83-86
Abstract:
Antibiotic target missed? The type II fatty acid synthesis (FASII) pathway has been suggested to be a promising antimicrobial target, and the antibiotics platensimycin and platencin that target this pathway are claimed to be potentially effective against multiresistant Gram-positive bacteria. But a new study casts doubt on the value of this approach. Clinical isolates of a series of Gram-positive pathogens, including staphylococci, streptococci, pneumococci, and enterococci, are shown to overcome drug-induced blockade of FASII pathway inhibition when supplied with exogenous fatty acids either in laboratory growth medium or when infecting animals. Importantly, human serum is a highly effective source of fatty acids.
Date: 2009
References: Add references at CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.nature.com/articles/nature07772 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:458:y:2009:i:7234:d:10.1038_nature07772
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/nature07772
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().